Second Dose Measles Vaccine Utilization and Associated Factors among Children Aged 24-36 Months in Western Guragae Zone, Central Ethiopia, 2024

Simple item page
dc.contributor.advisorDebela Gela
dc.contributor.authorFetiha Muzemil
dc.date.accessioned2025-08-12T19:15:33Z
dc.date.available2025-08-12T19:15:33Z
dc.date.issued2024-05
dc.description.abstractMeasles is a very contagious and terrible disease which causes serious illness in under five children, but it can be easily prevented and controlled by vaccination. Even if, Ethiopia launched measles second dose vaccine (MCV2) in 2019, only 9.1% of children aged 24 35 months received the second dose of the measles vaccine which is below the target. However little is known about the utilization and associated factors for MCV2 in the study area
dc.identifier.urihttps://etd.aau.edu.et/handle/123456789/6419
dc.language.isoen_US
dc.publisherAddis Ababa University
dc.subjectmeasles second dose vaccine
dc.subjectutilization
dc.subjectchildrenā€˜s
dc.subjectWestern Guragae Zone
dc.subjectEthiopia
dc.titleSecond Dose Measles Vaccine Utilization and Associated Factors among Children Aged 24-36 Months in Western Guragae Zone, Central Ethiopia, 2024
dc.typeThesis

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Fetih.pdf
Size:
1.85 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Health Sciences Education